Karen Daily, DO - Research

Research at a glance

Top areas of exploration

Breast Neoplasms , 10 publications
Neoplasms , 3 publications
Neoplasm Recurrence, Local , 3 publications
Antineoplastic Combined Chemotherapy Protocols , 3 publications

Research activity

41 publications

438 citations

Why is this important?

Active clinical trials

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cance

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications鈥�

Investigator: Karen Daily
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

41 publications

2018

Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review.

Clinical Medicine Insights. Oncology

鈥�

2018

Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti.

Journal of global oncology

鈥�

2018

The Toxicity of Time.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

鈥�

2018

Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcoma.

BMJ case reports

鈥�

2018

Women's 网红黑料 Curriculum for Medical Students.

Southern medical journal

鈥�

网红黑料

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review.

Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti.

The Toxicity of Time.

Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcoma.

Women's 网红黑料 Curriculum for Medical Students.